John Doyle | Vice President of Investor Relations & Finance |
Brian Stuglik | Chief Executive Officer |
Dan Paterson | President & Chief Operating Officer |
Rob Gagnon | Chief Financial & Business Officer |
Alethia Young | Cantor Fitzgerald |
Bert Hazlett | BTIG |
George Zavoico | B. Riley FBR |
Matthew Cross | Jones Trading |
Good afternoon, and welcome to the Verastem Oncology Second Quarter Financial Results Conference Call on Thursday, August 1, 2019. At this time, all participants are in a listen-only mode. There will be a question and answer session to follow. Please be advised that this call is being recorded at the company's request and will be available on the company's website for a period of 90 days from today.
At this time, I would like to introduce Mr.